Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

36.45p
   
  • Change Today:
    -0.30p
  • 52 Week High: 71.80p
  • 52 Week Low: 34.50p
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 173,211
  • Market Cap: £196.98m
  • RiskGrade: 119

Key dates

Dividend  
Latest XD Date (Final) 22-Jun-2023
Latest Pay Date (Final) 18-Jul-2023
   
Meetings  
AGM 25-May-2023
EGM n/a
GMs 23-May-2019
   
Announcements  
Trading announcement 29-Jan-2024
IMSs n/a
Drilling Report n/a
   
Results  
Final results 23-Apr-2024
Interim results 26-Sep-2023
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 12-Apr-2023
   
Year End 31-Dec-2024

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.45p
Change Today -0.30p
% Change -0.82 %
52 Week High 71.80p
52 Week Low 34.50p
Volume 173,211
Shares Issued 540.40m
Market Cap £196.98m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income
4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 19-Apr-2024

Time Volume / Share Price
13:05 8,650 @ 36.67p
12:36 2,136 @ 36.45p
12:26 1,000 @ 36.67p
12:24 700 @ 36.67p
11:25 2,710 @ 36.68p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page